Lycopene enhances bone neoformation in calvaria bone defects of ovariectomized rats
Authors:
- Vitória RicardoVRVitória Ricardo
- Luiz Gustavo de SousaLSLuiz Gustavo de Sousa
- Isabela Hallak RegaloIRIsabela Hallak Regalo
- Dimitrius Leonardo PitolDPDimitrius Leonardo Pitol
- Karina Fittipaldi Bombonato-PradoKBKarina Fittipaldi Bombonato-Prado
- Simone Cecilio Hallak RegaloSRSimone Cecilio Hallak Regalo
- Selma SiessereSSSelma Siessere
Open Access
- 1 June 2023
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Dental Journal
- Vol. 34 (3) , 50-56
Abstract
Osteoporosis can affect a significant part of the population and fractures are the most common complications associated with this disease, leading to high public health costs. Thus, the prevention of fractures is relevant to individuals with signs and symptoms as well as to the health system. Postmenopausal osteoporosis has been associated with oxidative stress, emphasizing the importance of an efficient defense system to maintain bone health. Lycopene is a carotenoid with antioxidant properties that may stimulate osteoblastogenesis and inhibit osteoclastogenesis. The purpose of this investigation was to analyze the influence of lycopene in the bone neoformation of calvaria defects in ovariectomized rats utilizing the concentration of 45 mg/kg. Wistar Hannover female rats were divided into ovariectomized and sham groups. The ovariectomized animals received 45 mg/kg lycopene (OvxL) or water (Ovx) by daily gavage the day after ovariectomy/sham surgery for 16 weeks. Twelve weeks after ovariectomy, there were performed 5-mm calvaria defects followed by euthanasia after 4 weeks. Samples of bone tissue were collected to perform morphological and morphometrical analysis of the neoformed bone area, and percentage with Software Image J. Morphological evaluation showed mature bone with more osteocytes in the group OVxL when compared to the other groups. The morphometrical analysis demonstrated a significant increase of bone neoformation in the group OvxL (p<0.05). The data obtained suggest that lycopene benefits bone repair in the absence of estrogenic hormones.Keywords
This publication has 25 references indexed in Scilit:
- Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis modelBone, 2016
- Oxidative Stress-Related Biomarkers in Postmenopausal Osteoporosis: A Systematic Review and Meta-AnalysesDisease Markers, 2016
- Effect of ovariectomy on serum adiponectin levels and visceral fat in ratsCurrent Medical Science, 2014
- The protective effect of lycopene intake on bone loss in ovariectomized ratsJournal of Bone and Mineral Metabolism, 2014
- Alterations in the osteocyte lacunar–canalicular microenvironment due to estrogen deficiencyBone, 2012
- Proliferation and differentiation of osteoblasts from the mandible of osteoporotic ratsExperimental Biology and Medicine, 2012
- Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal womenOsteoporosis International, 2010
- Osteoporosis Prevention, Diagnosis, and TherapyJAMA, 2001
- The ovariectomized rat model of postmenopausal bone lossBone and Mineral, 1991
- PRACTICAL STEREOLOGICAL METHODS FOR MORPHOMETRIC CYTOLOGYJournal of Cell Biology, 1966